Answers are grounded in this paper and cite their sources.
In the human body, pharmacological substances undergo biotransformation, therefore, during drugs development, it is necessary to take into account the biological activity spectra of their metabolites. Previously, we created the MetaPASS web application to analyze the probable spectra of biological activity of drug-like organic compounds taking into account their metabolism. Here we describe a new version of MetaPASS 2024 (https://www.way2drug.com/metapass), containing increased number of known metabolic pathways, and added procedures for searching structural similarity based on MNA and QNA descriptors and searching for compounds with the highest probability estimate for target biological activity; we have also implemented representation of the spectrum of biological activity in the form of treemaps.
No takes yet. Share an insight, caveat, or question.
Rudik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: